EphA2 as a Glioma-Associated Antigen: A Novel Target for Glioma Vaccines1
Under a Creative Commons license
open access
Keywords
EphA2
glioma
cancer vaccine
cytotoxic T lymphocytes
human leukocyte antigen (HLA) A2
Abbreviations
CTL
cytotoxic T lymphocyte
DC
dendritic cell
E/T ratio
effector-to-target ratio
HLA
human leukocyte antigen
IL
interleukin
PBMC
peripheral blood mononuclear cell
Cited by (0)
- 1
This work was supported by P01 NS40923 (I.F.R, H.O.), a Clinical Scientist Development Award from the Doris Duke Charitable Foundation (H.O.), a 21st Century Scientist Award from the James S. McDonnell Foundation (H.O.), the Copel, Fund of the Pittsburgh Foundation (H.O., NX.).
Copyright © 2005 Neoplasia Press, Inc. Published by Elsevier Inc.